(PR1C) Amundi Index Solutions - Ratings and Ratios
Corporate, Bond, ETF
Description: PR1C Amundi Index Solutions
Amundi Index Solutions - Amundi Prime Euro Corporates UCITS ETF DR (XETRA:PR1C) is an exchange-traded fund that tracks the Morningstar EZN Corp Bd GR EUR index, providing investors with exposure to a diversified portfolio of Euro-denominated corporate bonds. The fund is designed to deliver the total return of the underlying index, making it a suitable investment for those seeking to generate income and potentially benefit from capital appreciation.
The funds underlying index comprises a broad range of Euro corporate bonds, offering a diversified exposure to the European corporate bond market. By tracking this index, the ETF provides investors with a cost-effective and efficient way to gain access to this asset class, which can help to reduce overall portfolio risk and increase potential returns.
Analyzing the funds recent price action, we can observe that it has been trending upwards, with the short-term Simple Moving Average (SMA20) at 18.98 and the long-term SMA200 at 18.71. The Average True Range (ATR) is relatively low at 0.04, indicating stable price movements. Considering the current price of 19.01, we can expect the fund to continue its upward trend, potentially reaching the 52-week high of 19.06 in the near term.
Using a combination of technical and fundamental analysis, we can forecast the funds future performance. With Assets Under Management (AUM) standing at 1205.28M EUR, the fund has a significant presence in the market, which can contribute to its liquidity and stability. Based on the current technical indicators and fundamental data, we predict that the fund will continue to perform well, potentially reaching a price of 19.20 in the next 6-12 months, driven by the underlying indexs performance and the overall demand for Euro corporate bonds.
In conclusion, Amundi Prime Euro Corporates UCITS ETF DR (XETRA:PR1C) is a solid investment option for those seeking exposure to the European corporate bond market. With its diversified portfolio and cost-effective structure, the fund is well-positioned to deliver stable returns and potentially benefit from capital appreciation. Investors should continue to monitor the funds performance and adjust their investment strategies accordingly.
Additional Sources for PR1C ETF
PR1C ETF Overview
Market Cap in USD | 1,333m |
Category | EUR Corporate Bond |
TER | 0.07% |
IPO / Inception | 2019-02-05 |
PR1C ETF Ratings
Growth Rating | 5.82 |
Fundamental | - |
Dividend Rating | 53.1 |
Rel. Strength | 10.3 |
Analysts | - |
Fair Price Momentum | 18.23 EUR |
Fair Price DCF | - |
PR1C Dividends
Dividend Yield 12m | 2.17% |
Yield on Cost 5y | 2.15% |
Annual Growth 5y | 7.17% |
Payout Consistency | 96.6% |
Payout Ratio | % |
PR1C Growth Ratios
Growth Correlation 3m | 92.4% |
Growth Correlation 12m | 90.7% |
Growth Correlation 5y | -41.7% |
CAGR 5y | 0.06% |
CAGR/Max DD 5y | 0.00 |
Sharpe Ratio 12m | 0.73 |
Alpha | 0.49 |
Beta | 0.041 |
Volatility | 2.64% |
Current Volume | 30.7k |
Average Volume 20d | 13k |
Stop Loss | 18.5 (-3%) |
As of July 16, 2025, the stock is trading at EUR 19.08 with a total of 30,747 shares traded.
Over the past week, the price has changed by -0.14%, over one month by +0.15%, over three months by +1.58% and over the past year by +5.25%.
Neither. Based on ValueRay´s Analyses, Amundi Index Solutions is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 5.82 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PR1C is around 18.23 EUR . This means that PR1C is currently overvalued and has a potential downside of -4.45%.
Amundi Index Solutions has no consensus analysts rating.
According to our own proprietary Forecast Model, PR1C Amundi Index Solutions will be worth about 19.7 in July 2026. The stock is currently trading at 19.08. This means that the stock has a potential upside of +3.2%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 19.7 | 3.2% |